Richard R. De Haas
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Integrating Phenotypic Search and Phosphoproteomic Profiling of Active Kinases for Optimization of Drug Mixtures for RCC Treatment.
Journal: Cancers
Published: July 28, 2020
Feasibility of phosphoproteomics to uncover oncogenic signalling in secreted extracellular vesicles using glioblastoma-EGFRVIII cells as a model.
Journal: Journal of proteomics
Published: June 08, 2020
INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases.
Journal: Molecular systems biology
Published: May 26, 2019
INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases.
Journal: Molecular systems biology
Published: April 14, 2019
Alternative scheduling of pulsatile, high dose sunitinib efficiently suppresses tumor growth.
Journal: Journal of experimental & clinical cancer research : CR
Published: June 20, 2016
Differential effects of inhibitors of the PI3K/mTOR pathway on the expansion and functionality of regulatory T cells.
Journal: Clinical immunology (Orlando, Fla.)
Published: January 05, 2016
Sunitinib activates Axl signaling in renal cell cancer.
Journal: International journal of cancer
Published: October 04, 2015
Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanib.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: January 13, 2015
Acquired tumor cell resistance to sunitinib causes resistance in a HT-29 human colon cancer xenograft mouse model without affecting sunitinib biodistribution or the tumor microvasculature.
Journal: Oncoscience
Published: November 12, 2014
Lysosomal sequestration of sunitinib: a novel mechanism of drug resistance.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 08, 2011
Showing 1-12 of 12
Last Updated: 09/26/2026